Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 17;9(3):618.
doi: 10.3390/microorganisms9030618.

Recognizing the Benefits of Pre-/Probiotics in Metabolic Syndrome and Type 2 Diabetes Mellitus Considering the Influence of Akkermansia muciniphila as a Key Gut Bacterium

Raluca Anca Corb Aron  1 , Areha Abid  2 , Cosmin Mihai Vesa  1 , Aurelia Cristina Nechifor  3 , Tapan Behl  4 , Timea Claudia Ghitea  5 , Mihai Alexandru Munteanu  6 , Ovidiu Fratila  6 , Felicia Liana Andronie-Cioara  7 , Mirela Marioara Toma  5 , Simona Bungau  5
Affiliations
Review

Recognizing the Benefits of Pre-/Probiotics in Metabolic Syndrome and Type 2 Diabetes Mellitus Considering the Influence of Akkermansia muciniphila as a Key Gut Bacterium

Raluca Anca Corb Aron et al. Microorganisms. .

Abstract

Metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM) are diseases that can be influenced by the structure of gut microbiota, whose improvement is often neglected in metabolic pathology. This review highlights the following main aspects: the relationship between probiotics/gut microbes with the pathogenesis of MetS, the particular positive roles of Akkermansia muciniphila supplementation in the onset of MetS, and the interaction between dietary polyphenols (prebiotics) with gut microbiota. Therefore, an extensive and in-depth analysis of the often-neglected correlation between gut microbiota and chronic metabolic diseases was conducted, considering that this topic continues to fascinate and stimulate researchers through the discovery of novel strains and their beneficial properties.

Keywords: Akkermansia muciniphila; gut bacterium; metabolic syndrome; prebiotics; probiotics; type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of the selection process of the bibliographic sources included in this article.
Figure 2
Figure 2
A. muciniphila’s benefits in MetS.
See this image and copyright information in PMC

References

    1. Hays N.P., Galassetti P.R., Coker R.H. Prevention and treatment of type 2 diabetes: Current role of lifestyle, natural product, and pharmacological interventions. Pharmacol. Ther. 2008;118:181–191. doi: 10.1016/j.pharmthera.2008.02.003. - DOI - PMC - PubMed
    1. Monteagudo-Mera A., Rastall R.A., Gibson G.R., Charalampopoulos D., Chatzifragkou A. Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health. Appl. Microbiol. Biotechnol. 2019;103:6463–6472. doi: 10.1007/s00253-019-09978-7. - DOI - PMC - PubMed
    1. Pandey K.R., Naik S.R., Vakil B.V. Probiotics, prebiotics and synbiotics—A review. J. Food Sci. Technol. 2015;52:7577–7587. doi: 10.1007/s13197-015-1921-1. - DOI - PMC - PubMed
    1. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J. Nutr. 1995;125:1401–1412. doi: 10.1093/jn/125.6.1401. - DOI - PubMed
    1. Kneifel W. In vitro growth behaviour of probiotic bacteria in culture media with carbohydrates of prebiotic importance. Microb. Ecol. Health Dis. 2000;12:27–34. doi: 10.1080/089106000435563. - DOI

LinkOut - more resources